Notice for elexacaftor, tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
elexacaftor, tezacaftor, ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film-coated tablet; granules
Indication
For the treatment of cystic fibrosis
Therapeutic area
Respiratory